within Pharmacolibrary.Drugs.ATC.R;

model R06AB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 0.011666666666666665,
    adminDuration  = 600,
    adminMass      = 0.004,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 900
  );

  annotation(Documentation(
    info ="<html><body><p>Dexchlorpheniramine is a first-generation antihistamine, the dextrorotatory isomer of chlorpheniramine. It is primarily used for the symptomatic relief of allergic conditions such as hay fever, urticaria, and other allergic reactions. It is available as an over-the-counter and prescription medication in several countries, though its use has declined in favor of less sedating second-generation antihistamines.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult individuals after single oral administration.</p><h4>References</h4><ol><li><p>Coimbra, J, et al., &amp; Sánchez, C (2024). Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 203 106900–None. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2024.106900&quot;>10.1016/j.ejps.2024.106900</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39265704/&quot;>https://pubmed.ncbi.nlm.nih.gov/39265704</a></p></li><li><p>Alabazi, MY, &amp; Elzein, H (2012). An approach to formulating an oral floating drug delivery system for dexchlorpheniramine maleate using factorial design. <i>Die Pharmazie</i> 67(7) 611–617. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22888518/&quot;>https://pubmed.ncbi.nlm.nih.gov/22888518</a></p></li><li><p>Clissold, SP, &amp; Heel, RC (1984). Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. <i>Drugs</i> 28(6) 485–518. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198428060-00001&quot;>10.2165/00003495-198428060-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6394263/&quot;>https://pubmed.ncbi.nlm.nih.gov/6394263</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R06AB02;
